Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
Engagements
- 01Judge cites CRA expert Dr. Josh Sherman's testimony in antitrust trial rulingJudge Bazak-Rapaport’s decision rejected the parties’ narrow relevant market definition and agreed with and cited Dr. Sherman’s testimony from his...View engagement
- 02Expert defense of alleged generic drug price-fixing claims in Federal Court of CanadaA CRA Life Sciences team was retained on behalf of Canadian pharmaceutical manufacturers in a class action matter alleging a conspiracy to fix pricesView engagement
- 03Pro bono expert support for landmark settlement expanding mental-health services for New York’s Medicaid-insured childrenSean Taylor, Vice President in CRA’s Antitrust & Competition Practice, filed an expert report on behalf of plaintiffs, supported by a team of CRA consultants...View engagement
Meet our team
![Gregory Bell | Expert Witness | Charles River Associates]()
Gregory K. BellGroup Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.com![Peter Rankin Life Sciences Litigation Charles River Associates]()
![Andrew Tepperman | Life Sciences Litigation | Charles River Associates]()
![]()
![Archan Ruparel | Economist Expert Life Sciences | Charles River Associates]()
Latest insights
Recent events
ABA Bundled Rebates: Dissecting the Regeneron Trial Webinar
Last year, Regeneron took to trial its case alleging exclusionary conduct through bundled rebates by competitor Amgen. The jury found for Regeneron, awarding...
Getting to Know CRA’s Academic Experts: Zack Cooper
Is Going to a Private-Equity Owned Hospital Bad for Your Health? Private equity investment in health care has increased more than 20-fold—from $5 billion in...